Mesothelioma Lawyers - Gadolinium Lawyers - NSF Lawyers
MALIGNANT MESOTHELIOMA
Malignant mesothelioma is a fatal cancer affecting the mesothelial tissue of the heart, lungs and/or abdomen
DENTURE CREAM (POLIGRIP, FIXODENT)
Use of denture creams such as Poligrip and Fixodent linked to serious nervous disorders such as neuropathy and myelopathy.
JOHNSON & JOHNSON-DEPUY HIP REPLACEMENT
Two DePuy (a division of Johnson & Johnson) Hip Replacement products have been recalled and are the subject of potential lawsuits due to early failure.
SURGICAL AND TRANSVAGINAL MESH
Recent FDA warnings on surgical mesh conclude that Transvaginal placement to treat POP may expose patients to greater risk than other surgical options.
REGLAN (METOCLOPRAMIDE)
The FDA warns that use of Reglan (Metoclopramide) has been liked to tardive dyskinesia, which may include involuntary and repetitive movements of the body.
GADOLINIUM
Gadolinium is a chemical element used in an MRI that may cause nephrogenic systemic fibrosis (NSF).
BYETTA
The FDA announced that pancreatitis-related injuries and deaths continue to rise as a result of Byetta.
ACCUTANE
Roche Pharmaceuticals' Accutane has been linked to several gastrointestional disorders, including Crohn's Disease, Ulcerativecolitis, and IBD.
AVANDIA
GlaxoSmithKline's Avandia has come under increased scrutiny following reports linking the type 2 diabetes drug with serious adverse effects.
TRASYLOL SIDE EFFECTS
Trasylol, also known as aprotinin, received approval by the U.S. Food and Drug Administration in 1993 for the purpose of reducing bleeding in patients undergoing cardiopulmonary bypass during a coronary artery bypass graft...
MEDTRONIC RECALL
Medtronic, a leading manufacturer of medical devices, has voluntarily recalled several pacemaker and implantable defibrillator models due to serious defects...
GUIDANT RECALL
In June 2005, Guidant voluntarily recalled its implantable defibrillators due to the risk the device could experience an internal short circuit. This defect could prevent the defibrillator from delivering the shock required...
BEXTRA
Bextra is a non-steroidal anti-inflammatory prescription medication used to control tissue inflammation related to osteoarthritis and rheumatoid arthritis. It is part of a drug group known as COX 2 inhibitors, which includes major brand names such as Celebrex and Vioxx. Pfizer, the manufacturer of Bextra, voluntarily recalled the drug on April 17, 2005.
VIOXX RECALL
On September 30, 2004, Vioxx's manufacturer, Merck & Co., Inc. voluntarily removed the drug from the market after a study showed the drug increased a patient's risk of dangerous cardiovascular problems, including heart attacks and strokes.

- $11.5 million settlement on behalf of a 61 year old construction worker suffering from mesothelioma
- $11.0 million settlement on behalf of a 66 year old commercial plumber suffering from mesothelioma.
- $10.5 million settlement on behalf of a 51 year old residential plumber suffering from mesothelioma.
- $10.3 million verdict on behalf of a 60 year old shipyard worker suffering from mesothelioma

Levin Simes Kaiser & Gornick, LLP is one of the nation’s premier plaintiff side trial firms and has recovered over $400,000,000 on behalf of seriously injured individuals and their families. Our lawyers have represented thousands of individuals in products liability cases and tens of thousands of people in consumer protection class actions.
Whatever your consumer lawyer needs, whether it be a gadolinium lawyer, a mesothelioma lawyer, a NSF lawyer (nephrogenic systemic fibrosis), or a case involving one of a number of damaging pharmaceuticals, Levin Simes Kaiser & Gornick will give your case the attention it deserves.
Fill out the form below and a representative from our office will get back to you as soon as possible.

Levin Simes Kaiser & Gornick, LLP
44 Montgomery Street, 36th floor
San Francisco, CA 94104
Ph: 1-877-LSKG-LAW
(1-877-575-4529)
Fax: 415-981-1270
Our Specialties:
- Gadolinium
- Mesothelioma
- Nephrogenic Systemic Fibrosis
- Pharmaceuticals
- Medical Devices
Levin Simes Kaiser and Gornick LLP supports the Global Fibrosis Foundation












